Rostislav Novak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rostislav Novak has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Moreinos
Endodontic Department Galilee Medical Center Nahariya Israel
2 shared publications - David Nikomarov
Department of Orthopedic Surgery, Musculoskeletal Oncology Unit, Rambam Health Care Campus, Haifa 3109601, Israel
2 shared publications - Ilan Rotstein
Department of Endodontics and Periodontics, Herman Ostrow School of Dentistry, University of Southern California, Los Angeles, CA, USA
2 shared publications - Paul Vincent Abbott
UWA Dental School The University of Western Australia Perth Australia
2 shared publications - Shaul Lin
Department of Endodontics and Dental Trauma Rambam Health Care Campus Haifa Israel
2 shared publications A. M. Mavridou
Department of Endodontology National and Kapodistrian University of Athens Athens Greece
1 shared publication
Latest Publications
- Open Access
- 14 November 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 482
Primary ectopic meningioma of the brachial plexus: A case report and literature review
Background: Meningioma is the most common primary intracranial tumor. Less commonly, it may also arise extracranially in ectopic locations. Primary ectopic meningioma arising from the brachial plexus is extremely rare, with only two published cases. We present a case of primary brachial plexus meningioma, proven by histological analysis, and a review of the literature. Case Description: A 25-year-old man presented with swelling in the left supraclavicular region. Magnetic resonance imaging (MRI) demonstrated the presence of a mass arising from the brachial plexus. Initial pathological diagnosis and repeat biopsies were inconclusive and interpreted as a low-grade mesenchymal tumor with uncertain biologic potential. The proposed differential diagnosis included epithelioid schwannoma, atypical epithelioid neoplasm, or a low-grade malignancy. The fact that the differential diagnosis included both benign possibilities and low-grade malignancies raised complex questions about the preferred treatment plan. The surgical techniques necessary for each of these diagnoses vary. Typically, soft-tissue malignancies necessitate extensive resection, while in benign tumors, limited resection may suffice. Extensive resection within the brachial plexus carries substantial neurological and, therefore, functional morbidity. Finally, the patient underwent marginal resection of the tumor. The final pathological diagnosis was concluded as meningioma. The patient recovered completely, without neurological deficits, and repeated MRI demonstrated no residual or recurrence of the lesion. Conclusion: Although uncommon, we recommend considering the rare possibility of meningioma as a differential diagnosis for brachial plexus tumors, particularly in cases where the initial pathological examination is inconclusive for more prevalent tumors such as schwannoma and neurofibroma. Due to the rarity of this pathology, conclusive treatment recommendations cannot be made, especially regarding the decision to follow-up versus surgical resection. This debate is particularly pertinent in instances where the malignant potential of the pathology is uncertain and where surgical intervention carries a significant risk of functional impairment. We believe that maximal and safe surgical excision is the primary method of treatment, which potentially confers an excellent prognosis.
- 14 November 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 482
Open AccessPrimary ectopic meningioma of the brachial plexus: A case report and literature review
Background: Meningioma is the most common primary intracranial tumor. Less commonly, it may also arise extracranially in ectopic locations. Primary ectopic meningioma arising from the brachial plexus is extremely rare, with only two published cases. We present a case of primary brachial plexus meningioma, proven by histological analysis, and a review of the literature. Case Description: A 25-year-old man presented with swelling in the left supraclavicular region. Magnetic resonance imaging (MRI) demonstrated the presence of a mass arising from the brachial plexus. Initial pathological diagnosis and repeat biopsies were inconclusive and interpreted as a low-grade mesenchymal tumor with uncertain biologic potential. The proposed differential diagnosis included epithelioid schwannoma, atypical epithelioid neoplasm, or a low-grade malignancy. The fact that the differential diagnosis included both benign possibilities and low-grade malignancies raised complex questions about the preferred treatment plan. The surgical techniques necessary for each of these diagnoses vary. Typically, soft-tissue malignancies necessitate extensive resection, while in benign tumors, limited resection may suffice. Extensive resection within the brachial plexus carries substantial neurological and, therefore, functional morbidity. Finally, the patient underwent marginal resection of the tumor. The final pathological diagnosis was concluded as meningioma. The patient recovered completely, without neurological deficits, and repeated MRI demonstrated no residual or recurrence of the lesion. Conclusion: Although uncommon, we recommend considering the rare possibility of meningioma as a differential diagnosis for brachial plexus tumors, particularly in cases where the initial pathological examination is inconclusive for more prevalent tumors such as schwannoma and neurofibroma. Due to the rarity of this pathology, conclusive treatment recommendations cannot be made, especially regarding the decision to follow-up versus surgical resection. This debate is particularly pertinent in instances where the malignant potential of the pathology is uncertain and where surgical intervention carries a significant risk of functional impairment. We believe that maximal and safe surgical excision is the primary method of treatment, which potentially confers an excellent prognosis.
- Open Access
- 1 May 2025
- Published by Elsevier in Radiology Case Reports
- Vol. 20 (7) , 3465-3470
Calcific myonecrosis: Report of 4 cases and review
- 1 May 2025
- Published by Elsevier in Radiology Case Reports
- Vol. 20 (7) , 3465-3470
Open AccessCalcific myonecrosis: Report of 4 cases and review
- Open Access
- 18 September 2024
- Published by Wiley in International Endodontic Journal
- Vol. 57 (12) , 1727-1744
The role of infection in signalling root resorption: A narrative review
Background: Root resorption consists of complex, multistep processes that involve cell signalling caused by inflammation and stromal cells, which promotes the secretion of receptor activator of nuclear factor κB ligand/ macrophage‐colony stimulating factor (RANKL/M‐CSF) resulting in a resorptive process.Objective: The aim of this narrative review was to analyse the literature related to root resorption resulting from microbial infection and to comparing it with non‐microbial infection.Methods: An electronic literature search was performed using the PubMed database and applying keywords of articles published in English. Eligible papers were reviewed to reveal the descriptions of bone and root resorption processes. The abstracts were searched manually to identify articles about infection‐stimulating bone and root resorption.Results: Three main types of root resorption were identified, two associated with primary bacterial infection and one secondary to bacterial infection. These include external inflammatory resorption, internal inflammatory resorption and external cervical (invasive) resorption.Discussion: The magnitude of cytokine involvement that promotes resorption and M‐CSF/RANKL production depends on multiple factors, including pathogen virulence, site of infection and host genetic factors that activate the inflammation at the infection site. Two mechanisms activate the resorption mechanisms—the canonical and non‐canonical pathways that can activate clastic cells independently of the RANKL/RANK canonical pathways.Conclusions: Two pathways of root resorption co‐exist in the body. When resorption is caused by infection, chronic inflammation due to bacterial infection prolongs the secretions of pro‐inflammatory cytokines that intensify root and bone resorption. The second pathway is bacterial independent of the non‐infection root resorption that is part of the wound healing process, which is limited in time due to its innate ability.
- 18 September 2024
- Published by Wiley in International Endodontic Journal
- Vol. 57 (12) , 1727-1744
Open AccessThe role of infection in signalling root resorption: A narrative review
Background: Root resorption consists of complex, multistep processes that involve cell signalling caused by inflammation and stromal cells, which promotes the secretion of receptor activator of nuclear factor κB ligand/ macrophage‐colony stimulating factor (RANKL/M‐CSF) resulting in a resorptive process.Objective: The aim of this narrative review was to analyse the literature related to root resorption resulting from microbial infection and to comparing it with non‐microbial infection.Methods: An electronic literature search was performed using the PubMed database and applying keywords of articles published in English. Eligible papers were reviewed to reveal the descriptions of bone and root resorption processes. The abstracts were searched manually to identify articles about infection‐stimulating bone and root resorption.Results: Three main types of root resorption were identified, two associated with primary bacterial infection and one secondary to bacterial infection. These include external inflammatory resorption, internal inflammatory resorption and external cervical (invasive) resorption.Discussion: The magnitude of cytokine involvement that promotes resorption and M‐CSF/RANKL production depends on multiple factors, including pathogen virulence, site of infection and host genetic factors that activate the inflammation at the infection site. Two mechanisms activate the resorption mechanisms—the canonical and non‐canonical pathways that can activate clastic cells independently of the RANKL/RANK canonical pathways.Conclusions: Two pathways of root resorption co‐exist in the body. When resorption is caused by infection, chronic inflammation due to bacterial infection prolongs the secretions of pro‐inflammatory cytokines that intensify root and bone resorption. The second pathway is bacterial independent of the non‐infection root resorption that is part of the wound healing process, which is limited in time due to its innate ability.
- Open Access
- 15 September 2023
- Published by Wiley in International Endodontic Journal
- Vol. 56 (12) , 1432-1445
Pathogenesis of non‐infection related inflammatory root resorption in permanent teeth: A narrative review
Background: The mechanism of action of root resorption in a permanent tooth can be classified as infection‐related (e.g., microbial infection) or non‐infection‐related (e.g., sterile damage). Infection induced root resorption occurs due to bacterial invasion. Non‐infection‐related root resorption stimulates the immune system through a different mechanism.Objectives: The aim of this narrative review is to describe the pathophysiologic process of non‐infection‐related inflammatory processes involved in root resorption of permanent teeth.Methods: A literature search on root resorption was conducted using Scopus (PubMed and Medline) and Google Scholar databases to highlight the pathophysiology of bone and root resorption in non‐infection‐related situations. The search included key words covering the relevant category. It included in vitro and in vivo studies, systematic reviews, case series, reviews, and textbooks in English. Conference proceedings, lectures and letters to the editor were excluded.Results: Three types of root resorption are related to the non‐infection mechanism of action, which includes surface resorption due to either trauma or excessive orthodontic forces, external replacement resorption and external cervical resorption. The triggers are usually damage associated molecular patterns and hypoxia conditions. During this phase macrophages and clastic cells act to eliminate the damaged tissue and bone, eventually enabling root resorption and bone repair as part of wound healing.Discussion: The resorption of the root occurs during the inflammatory phase of wound healing. In this phase, damaged tissues are recognized by macrophages and neutrophiles that secrete interlaukines such as TNF‐α, IL‐1, IL‐6, IL‐8. Together with the hypoxia condition that accelarates the secretion of growth factors, the repair of the damaged perioduntiom, including damaged bone, is initiated. If the precementum and cementoblast are injured, root resorption can occur.Conclusions: Wound healing exhibits different patterns of action that involves immune stimulation in a bio‐physiological activity, that occurs in the proper sequence, with overlapping phases. Two pathologic conditions, DAMPs and hypoxia, can activate the immune cells including clastic cells, eliminating damaged tissue and bone. Under certain conditions, root resorption occurs as a side effect.
- 15 September 2023
- Published by Wiley in International Endodontic Journal
- Vol. 56 (12) , 1432-1445
Open AccessPathogenesis of non‐infection related inflammatory root resorption in permanent teeth: A narrative review
Background: The mechanism of action of root resorption in a permanent tooth can be classified as infection‐related (e.g., microbial infection) or non‐infection‐related (e.g., sterile damage). Infection induced root resorption occurs due to bacterial invasion. Non‐infection‐related root resorption stimulates the immune system through a different mechanism.Objectives: The aim of this narrative review is to describe the pathophysiologic process of non‐infection‐related inflammatory processes involved in root resorption of permanent teeth.Methods: A literature search on root resorption was conducted using Scopus (PubMed and Medline) and Google Scholar databases to highlight the pathophysiology of bone and root resorption in non‐infection‐related situations. The search included key words covering the relevant category. It included in vitro and in vivo studies, systematic reviews, case series, reviews, and textbooks in English. Conference proceedings, lectures and letters to the editor were excluded.Results: Three types of root resorption are related to the non‐infection mechanism of action, which includes surface resorption due to either trauma or excessive orthodontic forces, external replacement resorption and external cervical resorption. The triggers are usually damage associated molecular patterns and hypoxia conditions. During this phase macrophages and clastic cells act to eliminate the damaged tissue and bone, eventually enabling root resorption and bone repair as part of wound healing.Discussion: The resorption of the root occurs during the inflammatory phase of wound healing. In this phase, damaged tissues are recognized by macrophages and neutrophiles that secrete interlaukines such as TNF‐α, IL‐1, IL‐6, IL‐8. Together with the hypoxia condition that accelarates the secretion of growth factors, the repair of the damaged perioduntiom, including damaged bone, is initiated. If the precementum and cementoblast are injured, root resorption can occur.Conclusions: Wound healing exhibits different patterns of action that involves immune stimulation in a bio‐physiological activity, that occurs in the proper sequence, with overlapping phases. Two pathologic conditions, DAMPs and hypoxia, can activate the immune cells including clastic cells, eliminating damaged tissue and bone. Under certain conditions, root resorption occurs as a side effect.
- 5 May 2023
- Published by Wiley in Journal of Surgical Oncology
- Vol. 128 (4) , 660-666
Endoprosthetic reconstruction for lower extremity soft tissue sarcomas with bone involvement
Background and Objectives: Bone resection and endoprosthetic reconstruction (EPR) in the setting of soft tissue sarcoma (STS) management is rare and incurs unique challenges. We aim to report on the surgical and oncological outcomes of this relatively previously undocumented cohort.Methods: This is a single‐center retrospective review of prospectively collected data for patients who required EPRs following resection of STSs of the lower extremity. Following inclusion criteria, we assessed 29 cases of EPR for primary STS of the lower limb.Results: The mean age was 54 years (range 18–84). Of the 29 patients, there were 6 total femur, 11 proximal femur, 4 intercalary, and 8 distal femur EPRs. Fourteen of 29 patients (48%) underwent re‐operations for surgical complications, with 9 relating to infection (31%). When a matched cohort analysis was performed comparing our cohort to STSs that did not necessitate EPR, a reduced rate of overall survival and metastasis‐free survival was found in those requiring EPR.Conclusion: This series identifies a high rate of complication from EPRs performed for STS. Patients should be cautioned about the high rate of infection, surgical complications, and lower overall survival in this setting.
- 5 May 2023
- Published by Wiley in Journal of Surgical Oncology
- Vol. 128 (4) , 660-666
Endoprosthetic reconstruction for lower extremity soft tissue sarcomas with bone involvement
Background and Objectives: Bone resection and endoprosthetic reconstruction (EPR) in the setting of soft tissue sarcoma (STS) management is rare and incurs unique challenges. We aim to report on the surgical and oncological outcomes of this relatively previously undocumented cohort.Methods: This is a single‐center retrospective review of prospectively collected data for patients who required EPRs following resection of STSs of the lower extremity. Following inclusion criteria, we assessed 29 cases of EPR for primary STS of the lower limb.Results: The mean age was 54 years (range 18–84). Of the 29 patients, there were 6 total femur, 11 proximal femur, 4 intercalary, and 8 distal femur EPRs. Fourteen of 29 patients (48%) underwent re‐operations for surgical complications, with 9 relating to infection (31%). When a matched cohort analysis was performed comparing our cohort to STSs that did not necessitate EPR, a reduced rate of overall survival and metastasis‐free survival was found in those requiring EPR.Conclusion: This series identifies a high rate of complication from EPRs performed for STS. Patients should be cautioned about the high rate of infection, surgical complications, and lower overall survival in this setting.
- Open Access
- 24 September 2022
- Published by Springer Nature in Cell Death & Disease
- Vol. 13 (9) , 1-12
RNF4~RGMb~BMP6 axis required for osteogenic differentiation and cancer cell survival
Molecular understanding of osteogenic differentiation (OD) of human bone marrow-derived mesenchymal stem cells (hBMSCs) is important for regenerative medicine and has direct implications for cancer. We report that the RNF4 ubiquitin ligase is essential for OD of hBMSCs, and that RNF4-deficient hBMSCs remain as stalled progenitors. Remarkably, incubation of RNF4-deficient hBMSCs in conditioned media of differentiating hBMSCs restored OD. Transcriptional analysis of RNF4-dependent gene signatures identified two secreted factors that act downstream of RNF4 promoting OD: (1) BMP6 and (2) the BMP6 co-receptor, RGMb (Dragon). Indeed, knockdown of either RGMb or BMP6 in hBMSCs halted OD, while only the combined co-addition of purified RGMb and BMP6 proteins to RNF4-deficient hBMSCs fully restored OD. Moreover, we found that the RNF4-RGMb-BMP6 axis is essential for survival and tumorigenicity of osteosarcoma and therapy-resistant melanoma cells. Importantly, patient-derived sarcomas such as osteosarcoma, Ewing sarcoma, liposarcomas, and leiomyosarcomas exhibit high levels of RNF4 and BMP6, which are associated with reduced patient survival. Overall, we discovered that the RNF4~BMP6~RGMb axis is required for both OD and tumorigenesis.
- 24 September 2022
- Published by Springer Nature in Cell Death & Disease
- Vol. 13 (9) , 1-12
Open AccessRNF4~RGMb~BMP6 axis required for osteogenic differentiation and cancer cell survival
Molecular understanding of osteogenic differentiation (OD) of human bone marrow-derived mesenchymal stem cells (hBMSCs) is important for regenerative medicine and has direct implications for cancer. We report that the RNF4 ubiquitin ligase is essential for OD of hBMSCs, and that RNF4-deficient hBMSCs remain as stalled progenitors. Remarkably, incubation of RNF4-deficient hBMSCs in conditioned media of differentiating hBMSCs restored OD. Transcriptional analysis of RNF4-dependent gene signatures identified two secreted factors that act downstream of RNF4 promoting OD: (1) BMP6 and (2) the BMP6 co-receptor, RGMb (Dragon). Indeed, knockdown of either RGMb or BMP6 in hBMSCs halted OD, while only the combined co-addition of purified RGMb and BMP6 proteins to RNF4-deficient hBMSCs fully restored OD. Moreover, we found that the RNF4-RGMb-BMP6 axis is essential for survival and tumorigenicity of osteosarcoma and therapy-resistant melanoma cells. Importantly, patient-derived sarcomas such as osteosarcoma, Ewing sarcoma, liposarcomas, and leiomyosarcomas exhibit high levels of RNF4 and BMP6, which are associated with reduced patient survival. Overall, we discovered that the RNF4~BMP6~RGMb axis is required for both OD and tumorigenesis.
- Open Access
- 20 July 2012
- Published by Rambam Health Corporation in Rambam Maimonides Medical Journal
- Vol. 12 (3) , e0024
Bone Involvement in Hyperphosphatemic Familial Tumoral Calcinosis: A New Phenotypic Presentation
Mutations in FGF23, KL, and GALNT3 have been identified as the cause for the development of hyperphosphatemic familial tumoral calcinosis (HFTC). Patients with HFTC typically present in childhood or adolescence with periarticular soft tissue deposits that eventually progress to disrupt normal joint articulation. Mutations in the GALNT3 gene were shown to account for the hyperphosphatemic state in both HFTC and hyperostosis-hyperphosphatemia syndrome (HHS), the latter characterized by bone involvement. We present the case of a patient of a Druze ethnic origin with known HFTC that presented to our department with the first documented case of pathologic fracture occurring secondary to the disease. Our report introduces this new phenotypic presentation, suggests a potential role for prophylactic bone screening, and highlights the need for preconception genetic screening in selected populations.
- 20 July 2012
- Published by Rambam Health Corporation in Rambam Maimonides Medical Journal
- Vol. 12 (3) , e0024
Open AccessBone Involvement in Hyperphosphatemic Familial Tumoral Calcinosis: A New Phenotypic Presentation
Mutations in FGF23, KL, and GALNT3 have been identified as the cause for the development of hyperphosphatemic familial tumoral calcinosis (HFTC). Patients with HFTC typically present in childhood or adolescence with periarticular soft tissue deposits that eventually progress to disrupt normal joint articulation. Mutations in the GALNT3 gene were shown to account for the hyperphosphatemic state in both HFTC and hyperostosis-hyperphosphatemia syndrome (HHS), the latter characterized by bone involvement. We present the case of a patient of a Druze ethnic origin with known HFTC that presented to our department with the first documented case of pathologic fracture occurring secondary to the disease. Our report introduces this new phenotypic presentation, suggests a potential role for prophylactic bone screening, and highlights the need for preconception genetic screening in selected populations.